Abnormalities of cerebral oxidative metabolism in animal models of Parkinson disease.
Abnormalities of cerebral oxidative metabolism were investigated in "animal models" of Parkinson disease by in situ optical measurements of local cerebral blood volume and cytochrome oxidase redox shifts in rats two weeks after unilateral 6-hydroxydopamine lesions of the substantia nigra with or without interruption of ascending noradrenergic pathways. The data demonstrate oxidative metabolic dysfunction of ipsilateral cerebral hemispheres caused by lesions that involve both dopaminergic and noradrenergic systems but not when dopaminergic neurons only are affected. We speculate that the dementia of Parkinson disease may be more prevalent when degeneration of catecholaminergic systems is widespread and not restricted to the dopaminergic system.
D000818:Animals; D002540:Cerebral Cortex / Q000378:metabolism*; D003342:Corpus Striatum / Q000378:metabolism*; D003704:Dementia / Q000209:etiology*; D004195:Disease Models, Animal; D004298:Dopamine / Q000172:deficiency*; D003576:Electron Transport Complex IV / Q000378:metabolism; D006801:Humans; D008297:Male; D009638:Norepinephrine / Q000032:analysis*; D010084:Oxidation-Reduction; D010300:Parkinson Disease / Q000150:complications / Q000378:metabolism*; D051381:Rats
D003576:Electron Transport Complex IV; D004298:Dopamine; D009638:Norepinephrine